arXiv:2602. 04266v2 Announce Type: replace-cross Abstract: Aortic valve disease (AVD) represents a major public health burden, while its diagnosis relies on echocardiography, which is limited by cost and specialist expertise, restricting scalable screening and risk stratification.
arXiv:2606. 11125v1 Announce Type: cross Abstract: Blood pressure (BP) is a key marker for cardiovascular risk assessment and therapeutic decision-making, and Photoplethysmography (PPG) enables low-cost, wearable-friendly cuffless BP estimation.
arXiv:2606. 15284v1 Announce Type: cross Abstract: Photoplethysmography (PPG) plays a central role in wearable health monitoring and clinical decision support.
arXiv:2607. 23406v1 Announce Type: cross Abstract: Continuous cuffless blood pressure (BP) monitoring is essential for connected health systems and wearable devices, enabling early detection, longitudinal tracking, and personalized management of cardiovascular disease.
arXiv:2608. 14656v1 Announce Type: cross Abstract: Photoplethysmography (PPG) is widely used in consumer wearables because of its low cost and ease of acquisition.
arXiv:2606. 07365v1 Announce Type: cross Abstract: Photoplethysmography (PPG), a non-invasive measure of changes in blood volume, is widely used in both wearable devices and clinical settings.
arXiv:2608. 05893v1 Announce Type: new Abstract: Electrocardiography (ECG) is one of the most widely used non-invasive tools for diagnosing cardiovascular disease, but transforming multi-lead ECG recordings into reliable clinical reports remains challenging.
The study develops a 1‑D ResNet classifier that uses a fixed 17‑channel hemodynamic representation derived from photoplethysmography (PPG) to predict in‑hospital stroke risk states up to six hours before clinical recognition. Using data from MIMIC‑III and MC‑MED, the model achieved F1‑scores ranging from 0.7956 to 0.9888 across 4‑, 5‑, and 6‑hour horizons, outperforming four non‑waveform clinical and structured‑EHR comparators in all cohort‑horizon settings. Retrospective analysis showed that the PPG model’s false‑positive rates on high‑risk non‑stroke controls could be reduced through persistence aggregation, though the study does not establish a calibrated bedside alarm or a clinically validated prediction lead time.
arXiv:2609.13190v1 Announce Type: new Abstract: Continuous cuffless blood pressure (BP) monitoring using photoplethysmography (PPG) offers a promising solution for personalized healthcare. However, e...
arXiv:2607. 15721v1 Announce Type: new Abstract: Cardiometabolic diseases remain among the most persistent drivers of preventable morbidity because diabetes, hypertension, and cardiovascular disease frequently co-occur and share metabolic, vascular, demographic, and behavioral determinants.
The study investigates how adding ballistocardiography (BCG) signals to photoplethysmography (PPG) and arterial pressure wave (APW) signals affects the estimation of cardiovascular biomarkers. Using a unified whole‑body cardiovascular model, synthetic PPG, APW, and BCG signals were generated and analyzed with neural posterior estimation and simulation‑based inference. Results show that incorporating BCG significantly improves estimation accuracy, converting multimodal posterior distributions from PPG/APW alone into unimodal distributions, thereby enhancing the reliability of cardiovascular biomarker estimation.
arXiv:2608. 12944v1 Announce Type: new Abstract: Electrocardiography (ECG), photoplethysmography (PPG), and phonocardiography (PCG) provide complementary views of the same cardiac cycle, yet existing cardiac foundation models are trained for a single sensing modality, leaving the shared physiology across sensors unexploited.
arXiv:2607. 01145v1 Announce Type: new Abstract: Data analysis in the medical domain often encounters scenarios involving a limited target dataset and a large, unannotated dataset with a general distribution.